Home › Funds › venBio Partners LLC › PHVS

venBio Partners LLC position in PHVS

PHARVARIS N V · Health Care

venBio Partners LLC reported holding 4,643,430 shares of PHVS (PHARVARIS N V) in its Q2 2026 13F filing — a position valued at US$160.6M, representing 30.92% of its reported portfolio and ranking #1 among its reported holdings. venBio Partners LLC has disclosed PHVS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)4.64M sh
Reported value held$160.57M
Portfolio Weight30.92%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How venBio Partners LLC's PHVS position evolved

venBio Partners LLC first disclosed a stake in PHVS in Q3 2023 at 4,264,672 shares (US$89.0M). The position peaked in Q2 2026 at 4,643,430 shares, worth US$160.6M. Across 12 filings, venBio Partners LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 4,643,430 shares valued at US$160.6M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.26M $89.00M New
Q4 2023 4.92M $137.99M Add
Q1 2024 4.29M $99.13M Reduce
Q2 2024 4.29M $80.64M Hold
Q3 2024 4.29M $79.44M Hold
Q4 2024 4.29M $82.23M Hold
Q1 2025 4.29M $67.34M Hold
Q2 2025 4.29M $75.49M Hold
Q3 2025 4.64M $115.75M Add
Q4 2025 4.64M $128.74M Hold
Q1 2026 4.64M $131.06M Hold
Q2 2026 4.64M $160.57M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PHVS and 13F data

PHVS (PHARVARIS N V) is a Health Care company. 49 other funds we track also report a position in PHVS — the largest reported positions include GENERAL ATLANTIC, L.P. (US$226.5M), Foresite Capital Management IV, LLC (US$165.2M), EQT Fund Management S.a r.l. (US$118.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PHVS

All PHVS fund holders →

FAQ

How long has venBio Partners LLC held PHVS?

venBio Partners LLC has disclosed PHVS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is venBio Partners LLC's current position in PHVS?

As of Q2 2026, venBio Partners LLC holds 4.64M shares of PHVS (PHARVARIS N V), valued at $160.57M, representing 30.92% of its reported portfolio and ranking #1.

Has venBio Partners LLC been buying or selling PHVS?

In the latest 13F filing (Q2 2026), venBio Partners LLC held unchanged its position in PHVS. The position peaked in Q2 2026 at 4.64M shares.

Which other funds hold PHVS?

Other major institutional holders of PHVS include GENERAL ATLANTIC, L.P., Foresite Capital Management IV, LLC, EQT Fund Management S.a r.l., among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.